Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

TerrAscend Corp.

Healthcare CA TSND

0.93CAD
-0.04(4.12%)

Last update at 2026-06-03T19:56:00Z

Day Range

0.920.99
LowHigh

52 Week Range

0.302.00
LowHigh

Fundamentals

  • Previous Close 0.97
  • Market Cap335.75M
  • Volume123675
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA60.12M
  • Revenue TTM260.56M
  • Revenue Per Share TTM0.86
  • Gross Profit TTM 136.32M
  • Diluted EPS TTM-0.14

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 5.06M -52.23200M -79.40613M -403.81542M 55.83M
Minority interest -4.89700M - - - -
Net income -87.73747M -80.23200M -128.95584M -429.49188M 3.90M
Selling general administrative 82.41M 105.20M 100.35M 101.22M 71.85M
Selling and marketing expenses - 6.13M 9.66M 10.32M 1.86M
Gross profit 133.19M 149.96M 202.81M 119.57M 134.11M
Reconciled depreciation 17.22M - - - -
Ebit - -16.83000M 47.34M -30.90861M 39.95M
Ebitda 45.41M 6.16M 77.98M 1.12M 57.33M
Depreciation and amortization - 22.98M 30.64M 32.03M 17.38M
Non operating income net other - - - - -
Operating income 45.41M -17.10600M 47.34M -30.90861M 39.95M
Other operating expenses 219.71M 323.78M 380.95M 353.55M 203.54M
Interest expense 36.93M 35.40M 35.11M 39.06M 24.99M
Tax provision 29.47M 20.44M - -10.78300M 28.31M
Interest income - 32.03M - 25.73M 33.23M
Net interest income -35.40300M - - - -
Extraordinary items - 0.00000M - -25.94900M -
Non recurring - - - - -
Other items - - - - -
Income tax expense 29.98M 20.44M 31.65M -14.03789M 36.20M
Total revenue 265.12M 306.68M 428.29M 322.64M 243.49M
Total operating expenses 87.78M 167.07M 155.47M 150.48M 94.16M
Cost of revenue 131.93M 156.72M 225.48M 203.07M 109.38M
Total other income expense net -40.34409M -35.12600M -126.74775M -372.90681M 15.88M
Discontinued operations - - - - -
Net income from continuing ops -24.48900M - - - -
Net income applicable to common shares - -80.23200M - -329.90800M 3.11M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 566.83M 607.23M 878.87M 701.59M 581.93M
Intangible assets 167.01M 169.60M 215.85M 239.70M 168.98M
Earning assets - - - - -
Other current assets 21.23M 0.61M 6.46M 18.52M 0.10M
Total liab 467.99M 430.27M 561.43M 382.79M 358.35M
Total stockholder equity 97.31M 176.96M 319.76M 318.80M 223.59M
Deferred long term liab - - - - -
Other current liab 25.03M - 15.74M - -
Common stock - 0.00000M - 0.00000M 0.00000M
Capital stock 0.00000M - - - -
Retained earnings -863.16830M -778.51400M -928.50801M -618.26000M -314.65400M
Other liab - - - - -
Good will 109.57M 106.93M 141.00M 90.33M 90.33M
Other assets - 0.89M - 4.30M 9.08M
Cash 37.46M - 33.42M - -
Cash and equivalents - 26.38M - 26.16M 79.64M
Total current liabilities 79.79M 78.53M 272.95M 137.91M 70.36M
Current deferred revenue - - 5.48M - -
Net debt 219.03M - 303.74M - -
Short term debt 17.19M 0.00000M 185.94M 0.00000M 0.00000M
Short long term debt 15.68M - - - -
Short long term debt total 256.49M - 337.17M - -
Other stockholder equity 958.49M 3.01M 1245.89M 2.08M 2.82M
Property plant equipment - 225.37M - 245.26M 170.32M
Total current assets 109.91M 104.43M 135.67M 121.99M 143.22M
Long term investments - - - - -
Net tangible assets - - - - -
Short term investments 0.36M 1.73M 2.52M 3.60M -
Net receivables 16.87M 18.89M 25.12M 4.23M 14.19M
Long term debt 210.74M 192.57M - 145.85M 176.31M
Inventory 33.99M 48.80M 68.15M 46.34M 42.32M
Accounts payable 37.57M - 65.79M - -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.98M - 2.37M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 13.54M - 104.41M - -
Deferred long term asset charges - - - - -
Non current assets total 456.93M - 743.20M - -
Capital lease obligations 30.07M - - - -
Long term debt total - 192.57M - 152.56M 207.06M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - - - -
Change to liabilities - - - - -
Total cashflows from investing activities -15.03059M -12.24700M - -27.57900M -132.42100M
Net borrowings 8.45M - - - -
Total cash from financing activities 4.26M -24.71600M -16.87109M 4.84M 228.43M
Change to operating activities - - - - -
Net income -29.90042M -72.67000M -122.95783M -395.71008M 15.83M
Change in cash 9.19M 1.64M -2.83997M -64.33727M 25.19M
Begin period cash flow 28.26M 25.35M 36.26M 100.60M 75.41M
End period cash flow 37.46M 26.99M 33.42M 36.26M 100.60M
Total cash from operating activities 22.07M 37.95M 37.08M -33.33786M -38.45072M
Issuance of capital stock 0.00000M - - - -
Depreciation 17.22M 22.98M 30.64M 32.03M 17.38M
Other cashflows from investing activities 3.16M -2.63500M - 14.31M -93.55100M
Dividends paid - - - - -
Change to inventory 6.05M 4.17M -6.99813M 0.88M -23.20408M
Change to account receivables 1.67M -2.95000M -12.49675M 3.73M -4.02323M
Sale purchase of stock -0.41718M -0.21500M - 24.34M 204.26M
Other cashflows from financing activities -3.68642M -7.32400M -6.05065M -20.46383M -22.97716M
Change to netincome - - - - -
Capital expenditures 8.76M 10.55M 12.72M 54.54M 50.41M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 23.24M 28.84M 45.13M 0.04M -45.19706M
Stock based compensation 5.01M 9.71M 7.71M 12.16M 14.94M
Other non cash items 28.73M 57.84M 189.29M 451.47M 33.55M
Free cash flow 13.31M 27.40M 24.35M -87.87511M -88.86457M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TSND
TerrAscend Corp.		 -0.04 4.12% 0.93 - 36.10 1.29 2.28 1.70 7.56
CURA
Curaleaf Holdings Inc.		 -0.24 4.83% 4.73 - 138.89 2.57 3.14 2.47 13.10
BHC
Bausch Health Companies Inc		 -0.07 1.00% 6.90 13.98 1.35 0.28 18.74 2.12 6.84
CRON
Cronos Group Inc		 -0.01 0.27% 3.76 - 32.15 9.80 0.95 1.47 1.90
TLRY
Tilray Inc		 -0.28 3.76% 7.16 - 1000.00 1.28 0.53 1.08 -2.299

Reports Covered

Stock Research & News

View All

Profile

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries under the Apothecarium brand name. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

TerrAscend Corp.

77 City Centre Drive, East Tower, Mississauga, ON, Canada, L5B 1M5

Key Executives

Name Title Year Born
Mr. Jason Garrett Wild R.Ph. Executive Chairman 1973
Mr. Ziad Ghanem President & CEO 1978
Mr. Keith Stauffer Chief Financial Officer 1970
Ms. Lynn Gefen Chief Legal Officer & Corporate Secretary 1971
Mr. David Wheeler Senior VP & Chief Information Officer NA
Mr. BJ Carretta Senior Vice President of Marketing NA
Mr. Jeroen De Beijer Chief People & Culture Officer NA
Ms. Lynn Gefen J.D. Chief People Officer, Chief Legal Officer & Corporate Secretary 1971
Ms. Alisa Campbell Senior Vice President of Corporate Finance & Accounting NA
Mr. Ziad Ghanem President & CEO 1979

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions